(13-394) Operational, economic, and clinical outcomes of real-world conversion from peg-filgrastim On-Body Injector (OBI) to peg-filgrastim biosimilars in an outpatient oncology setting
Wednesday, December 6, 2023
3:15 PM - 4:15 PM
Location: Hall E, Lower Level
Co-Author(s): Michael Goldenhorn, Benjamin Levy, Douglas Mazewski
